Corteva Q2 Earnings Call Highlights

Corteva raised its 2026 outlook after strong first-half results, now targeting operating EBITDA of $4.1 billion–$4.3 billion and operating EPS of $3.60–$3.80. First-half sales rose 4% to $11.3 billion, while EBITDA increased 10% to $3.7 billion. Growth was supported by seed demand, licensing income, newer crop-protection products and cost savings, which offset pricing pressure in crop protection—particularly in Brazil. Management expects low-double-digit seed sales growth and high-single-digit crop-protection volume growth in the second half. Corteva remains on schedule and under budget to separate its businesses on Oct. 1, with the advanced seed and genetics company to operate as Vylor. The company has appointed leadership, filed its separation documents and expects significantly lower separation-related dis-synergies than previously projected.

Corteva CTVA raised its full-year outlook after reporting higher first-half sales, earnings and margins, citing demand for its seed technologies, growth in new crop-protection products, licensing income and cost discipline. The agricultural company also said it remains on schedule to separate its businesses on Oct. 1, with its advanced seed and genetics company expected to operate as Vylor. For the first half of 2026, net sales increased 4% to $11.3 billion, while organic sales rose 2%. Operating EBITDA increased 10% year over year to $3.7 billion, and operating EPS increased 14%, Chief Executive Officer Chuck Magro said. Operating EBITDA margin expanded to 32.8%, an increase of nearly 200 basis points, according to Chief Financial Officer David Johnson.

Corteva raised its 2026 operating EBITDA forecast to a range of $4.1 billion to $4.3 billion and increased its operating EPS outlook to $3.60 to $3.80 per share. At the midpoint, the company said the updated outlook implies approximately 9% EBITDA growth and 11% EPS growth from the prior year. The company also lifted its operating EBITDA margin outlook to 22.5% to 23.5%. Johnson said higher net interest expense would partially offset EBITDA gains, but management continues to expect earnings growth and margin expansion. Management expects second-half EBITDA to be approximately flat from the prior year. The company said the back half will include the effects of tariffs, separation dis-synergies and the Middle East conflict, while the third quarter is expected to post an operating EBITDA loss broadly comparable with the loss recorded in the third quarter of 2024. Corteva expects all second-half earnings to be delivered in the fourth quarter. First-half price and mix contributed nearly $100 million to EBITDA growth. Volume added about $40 million, supported by North American seed demand and high-single-digit growth in crop-protection new products. Cost performance added more than $160 million through lower input costs, manufacturing efficiencies and productivity efforts. Currency provided an approximately $85 million benefit, primarily related to the euro. Improved seed net royalties contributed about $90 million, as lower royalty expense and higher royalty income positioned the company to be net royalty positive for the year.

Seed organic sales increased by low single digits during the first half, with growth in every region led by North America and Europe, the Middle East and Africa. Johnson said demand continued for the company’s differentiated techn...